111 related articles for article (PubMed ID: 17101047)
1. Characterizing exons 11 and 1 promoters of the mu opioid receptor (Oprm) gene in transgenic mice.
Xu J; Xu M; Pan YX
BMC Mol Biol; 2006 Nov; 7():41. PubMed ID: 17101047
[TBL] [Abstract][Full Text] [Related]
2. Goat uromodulin promoter directs kidney-specific expression of GFP gene in transgenic mice.
Huang YJ; Chretien N; Bilodeau AS; Zhou JF; Lazaris A; Karatzas CN
BMC Biotechnol; 2005 Apr; 5():9. PubMed ID: 15823198
[TBL] [Abstract][Full Text] [Related]
3. Generation of a transgenic zebrafish model of Tauopathy using a novel promoter element derived from the zebrafish eno2 gene.
Bai Q; Garver JA; Hukriede NA; Burton EA
Nucleic Acids Res; 2007; 35(19):6501-16. PubMed ID: 17897967
[TBL] [Abstract][Full Text] [Related]
4. Mouse mu opioid receptor gene expression. A 34-base pair cis-acting element inhibits transcription of the mu opioid receptor gene from the distal promoter.
Choe Cy; Im HJ; Ko JL; Loh HH
J Biol Chem; 1998 Dec; 273(52):34926-32. PubMed ID: 9857022
[TBL] [Abstract][Full Text] [Related]
5. Selective activation of sar promoters with the use of green fluorescent protein transcriptional fusions as the detection system in the rabbit endocarditis model.
Cheung AL; Nast CC; Bayer AS
Infect Immun; 1998 Dec; 66(12):5988-93. PubMed ID: 9826382
[TBL] [Abstract][Full Text] [Related]
6. Use of a ROSA26:GFP transgenic line for long-term Xenopus fate-mapping studies.
Gross JB; Hanken J; Oglesby E; Marsh-Armstrong N
J Anat; 2006 Sep; 209(3):401-13. PubMed ID: 16928208
[TBL] [Abstract][Full Text] [Related]
7. Directed expression of transgenes to alveolar type I cells in the mouse.
Vanderbilt JN; Allen L; Gonzalez RF; Tigue Z; Edmondson J; Ansaldi D; Gillespie AM; Dobbs LG
Am J Respir Cell Mol Biol; 2008 Sep; 39(3):253-62. PubMed ID: 18367724
[TBL] [Abstract][Full Text] [Related]
8. Differential expressions of the alternatively spliced variant mRNAs of the µ opioid receptor gene, OPRM1, in brain regions of four inbred mouse strains.
Xu J; Lu Z; Xu M; Rossi GC; Kest B; Waxman AR; Pasternak GW; Pan YX
PLoS One; 2014; 9(10):e111267. PubMed ID: 25343478
[TBL] [Abstract][Full Text] [Related]
9. Differential gene expression activity among species-specific polypyrimidine/polypurine motifs in mu opioid receptor gene promoters.
Choe CY; Dong J; Law PY; Loh HH
Gene; 2011 Jan; 471(1-2):27-36. PubMed ID: 20946943
[TBL] [Abstract][Full Text] [Related]
10. Human OPRM1 and murine Oprm1 promoter driven viral constructs for genetic access to μ-opioidergic cell types.
Salimando GJ; Tremblay S; Kimmey BA; Li J; Rogers SA; Wojick JA; McCall NM; Wooldridge LM; Rodrigues A; Borner T; Gardiner KL; Jayakar SS; Singeç I; Woolf CJ; Hayes MR; De Jonghe BC; Bennett FC; Bennett ML; Blendy JA; Platt ML; Creasy KT; Renthal WR; Ramakrishnan C; Deisseroth K; Corder G
Nat Commun; 2023 Sep; 14(1):5632. PubMed ID: 37704594
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the mouse TgTP6.3 tauGFP transgene as a lineage marker in chimeras.
MacKay GE; Keighren MA; Wilson L; Pratt T; Flockhart JH; Mason JO; Price DJ; West JD
J Anat; 2005 Jan; 206(1):79-92. PubMed ID: 15679873
[TBL] [Abstract][Full Text] [Related]
12. Genetic mouse models for bone studies--strengths and limitations.
Elefteriou F; Yang X
Bone; 2011 Dec; 49(6):1242-54. PubMed ID: 21907838
[TBL] [Abstract][Full Text] [Related]
13. Correction: A novel transgenic mouse line with hippocampus-dominant and inducible expression of truncated human tau.
Gao Y; Wang Y; Lei H; Xu Z; Li S; Yu H; Xie J; Zhang Z; Liu G; Zhang Y; Zheng J; Wang JZ
Transl Neurodegener; 2024 Jan; 13(1):5. PubMed ID: 38212846
[No Abstract] [Full Text] [Related]
14. Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene,
Liu S; Kang WJ; Abrimian A; Xu J; Cartegni L; Majumdar S; Hesketh P; Bekker A; Pan YX
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680158
[TBL] [Abstract][Full Text] [Related]
15. Isolating and characterizing three alternatively spliced mu opioid receptor variants: mMOR-1A, mMOR-1O, and mMOR-1P.
Xu J; Xu M; Bolan E; Gilbert AK; Pasternak GW; Pan YX
Synapse; 2014 Apr; 68(4):144-52. PubMed ID: 24375714
[TBL] [Abstract][Full Text] [Related]
16. Mu opioids and their receptors: evolution of a concept.
Pasternak GW; Pan YX
Pharmacol Rev; 2013; 65(4):1257-317. PubMed ID: 24076545
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of the μ-opioid receptor by truncated single transmembrane splice variants through a chaperone-like action.
Xu J; Xu M; Brown T; Rossi GC; Hurd YL; Inturrisi CE; Pasternak GW; Pan YX
J Biol Chem; 2013 Jul; 288(29):21211-21227. PubMed ID: 23760268
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional and epigenetic regulation of opioid receptor genes: present and future.
Wei LN; Loh HH
Annu Rev Pharmacol Toxicol; 2011; 51():75-97. PubMed ID: 20868272
[TBL] [Abstract][Full Text] [Related]
19. Expansion of the human mu-opioid receptor gene architecture: novel functional variants.
Shabalina SA; Zaykin DV; Gris P; Ogurtsov AY; Gauthier J; Shibata K; Tchivileva IE; Belfer I; Mishra B; Kiselycznyk C; Wallace MR; Staud R; Spiridonov NA; Max MB; Goldman D; Fillingim RB; Maixner W; Diatchenko L
Hum Mol Genet; 2009 Mar; 18(6):1037-51. PubMed ID: 19103668
[TBL] [Abstract][Full Text] [Related]
20. Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene.
Xu J; Xu M; Hurd YL; Pasternak GW; Pan YX
J Neurochem; 2009 Feb; 108(4):962-72. PubMed ID: 19077058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
